Therapeutic hepatitis vaccine - VLP Biotech
Alternative Names: HBV/HDV vaccine; PreS1-WHc VLPsLatest Information Update: 28 Sep 2023
At a glance
- Originator ChronTech Pharma; Vaccine Research Institute of San Diego
- Developer VLP Biotech
- Class Hepatitis B vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Hepatitis D
- No development reported Hepatitis B
Most Recent Events
- 28 Sep 2023 No recent reports of development identified for preclinical development in Hepatitis-B in USA (Intraperitoneal)
- 24 Feb 2021 Therapeutic hepatitis vaccine is available for licensing as of 16 Jul 2021
- 24 Feb 2021 Preclinical trials in Hepatitis D in USA (Intraperitoneal) before February 2021